branch graphic

Who we are and what we do

Who we are and what we do

The information shown here is current information only.

How we fit into the NHS Structure

CCGS are new organisations, led by a team of local clinicians such as GPs, Consultants and nurses which have taken over from the old Primary Care Trusts.

NHS Barnsley CCG has been established as part of the major changes to the NHS set out in the 2010 White Paper Equity and Excellence - Liberating the NHS which became law under the Health and Social Care Act 2012.

From April 2013 Primary Care Trusts were abolished under the 2012 Act and Clinical Commissioning Groups became responsible for commissioning or buying health and care services including:

  • Elective hospital care
  • Rehabilitation care
  • Urgent and emergency care
  • Most community health services
  • Mental health and learning disability services

CCGs will now be overseen by NHS England, which is a national body formed under the 2012 Act. Local offices of NHS England will oversee their local CCGs such as Barnsley and also manage primary care commissioning, including holding GP practices NHS contracts.

As well as creating CCGs and the NCB (NHS Commissioning Board), the Act establishes several other new bodies including:

  • Healthwatch England - responsible for providing advice on the views of local organisations and service users.
  • NHS Digital - responsible for publishing and assessing the quality of information produced by health and social care bodies.
  • Public Health England - responsible for public health.

Alongside development of the CCGs, Commissioning Support Units (CSU) have also been developed. The CSU contracts with several local CCGs to provide a range of functions, including HR support, contracting, finance, information governance and IT services. In early 2013, it was agreed that West Yorkshire would join South Yorkshire and Bassetlaw to create West and South Yorkshire and Bassetlaw Commissioning Support Unit spanning a population of 3.9 million people. 

Equity and Excellence - Liberating the NHS
The NHS White Paper, Equity and excellence: Liberating the NHS, sets out the Government's long-term vision for the future of the NHS.

The NHS Constitution For England
The NHS Constitution has been created to protect the NHS and make sure it will always do the things it was set up to do in 1948 - to provide high-quality healthcare that’s free and for everyone.
The NHS Constitution will also make sure that no government can change the way the NHS works without getting the approval of staff, patients and the public. The Constitution is a promise that the NHS will always be there for you. 

National Service Frameworks
National service frameworks (NSFs) and strategies set clear quality requirements for care. These are based on the best available evidence of what treatments and services work most effectively for patients.

One of the main strengths of each strategy is that it is inclusive, having been developed in partnership with health professionals, patients, carers, health service managers, voluntary agencies and other experts.

There are frameworks and strategies in place for:

  • Cancer
  • Children
  • Coronary Heart Disease
  • Diabetes
  • Long Term Conditions
  • Lung health
  • Mental Health
  • Older People
  • Renal Services
  • Stroke

Department of Health Operating Framework 2012/13
The operating framework for the NHS in England for 2012/13 sets out the priorities for the NHS for the year ahead to enable them to beginning their planning.

Organisational structure

Committee Structure November 2018

Lists of and information relating to key organisations we work in partnership with

(Barnsley CCG is committed to working in partnership with a range of organisations such as these shown below)

Meetings with pharmaceutical companies and other medical suppliers

CCG Meetings with Pharmaceutical Representatives

Chris Lawson Head of Medicines Optimisation met  with:-

  1. 13th May 2015 - Bayer PLC representative  Karen Turner and colleague : To discuss Newer Oral Anticoagulant (Rivaroxaban)use in AF and DVT
  2. 26th June 2016 – Astrazeneca UK Ltd representative Richard O’Toole : To discuss Oxis Turbohaler and Goserelin.
  3. 2nd July 2019 - Harpreet Pangli – Regional Business Manager ( Fontus)  & Laura Hallas, Tissue Viability Nurse Specialist (SWYFT) : To discuss Aproderm emollient range and Zaluron XL manufactured by Fontus in relation to evidence base and costs of products

Senior executives and management board/Governing Body members

Barnsley CCG Headquarters

Hillder House, 49 - 51 Gawber Road, Barnsley, S75 2PY or visit the Contact Us page